Collaborations & Alliances
-
Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Alkermes, Merck Enter Clinical Trial and Supply Agreement
To evaluate nemvaleukin alfa in combination with Keytruda in patients with platinum-resistant ovarian cancer.Tim Wright, Editor, Contract Pharma 04.07.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals
Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.Tim Wright, Editor, Contract Pharma 04.07.21
-
Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development | Industry News
Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
Work together to develop and commercialize CHI’s novel dry-powder inhaler product.Charles Sternberg, Assistant Editor 04.07.21
-
Breaking News | Collaborations & Alliances | Industry News
CordenPharma Enters Alliance with Nanos of South Korea
Partnership represents Nanos’ intention to establish long-term production and sale of therapeutic drugs involving peptides.Tim Wright, Editor, Contract Pharma 04.05.21
-
Aseptic Processing | Breaking News | Collaborations & Alliances | Industry News
Steriline Delivers New Manufacturing Line to Bess Pro
Provided a turnkey line, fully operating and ready to perform at full capacity.Charles Sternberg, Assistant Editor 03.31.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News
GSK Supports Manufacture of Novavax’ COVID-19 Vaccine
GSK will provide fill and finish manufacturing capacity for up to 60 million doses at its Barnard Castle facility.Tim Wright, Editor, Contract Pharma 03.31.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News | Parenterals
Jubilant, Novavax Enter COVID-19 Vaccine Partnership
Jubilant to provide fill-finish manufacturing services for the production of COVID-19 vaccine candidate NVX-CoV2373.Tim Wright, Editor, Contract Pharma 03.29.21
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity
Utilizing ABEC Custom Single Run technology to increase flexibility and productivity.Tim Wright, Editor, Contract Pharma 03.25.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
CyanVac and Exothera Enter COVID-19 Vaccine Partnership
CDMO Exothera selected for the development and GMP manufacturing of intranasal vaccine candidate for Phase III clinical trial is Europe and the U.S.Tim Wright, Editor, Contract Pharma 03.25.21
-
Breaking News | cGMP Manufacture | Collaborations & Alliances
BioCentriq, Kytopen Enter Cell Therapy Alliance
Demonstrates the impact of transformative technology on cell therapy manufacturing.Charles Sternberg, Assistant Editor 03.24.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
BioCentriq and Kytopen Enter Cell Therapy Partnership
To show the impact to autologous and allogeneic cell therapies by integrating novel transfection technology with other steps in the manufacturing process.Tim Wright, Editor, Contract Pharma 03.23.21
-
Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Plus Therapeutics, Piramal Ink Master Services Agreement
Development, manufacturing and supply deal is for Plus’ Rhenium NanoLiposome intermediate drug product.Tim Wright, Editor, Contract Pharma 03.23.21
-
Breaking News | Collaborations & Alliances
Thermo Fischer Scientific Collaborates with Protein Metrics
Will facilitate precise, reliable mass spectrometry data processing and drive innovation for biopharmaceutical and proteomics applications.Charles Sternberg, Assistant Editor 03.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, Takeda Enter Multi-RNA Target Alliance
To discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.Kristin Brooks 03.22.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
RDIF & Stelis Enter Covid-19 Vaccine Supply Deal
Partner to supply 200 million doses of the Sputnik V vaccine.Tim Wright, Editor, Contract Pharma 03.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Catalent Expands Partnership with J&J
To significantly increase capacity for sterile manufacturing and packaging of COVID-19 vaccine in Italy.Tim Wright, Editor, Contract Pharma 03.17.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Fujifilm and Sana Biotechnology Enter Cell Therapy Partnership
Enter license agreement for the development of iPSC-derived cell therapies.Tim Wright, Editor, Contract Pharma 03.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News | Parenterals
WuXi Biologics to Acquire Manufacturing Facilities from Pfizer China
Immediately boosts commercial Drug Substance and Drug Product capacities for WuXi Biologics to address surging manufacturing demands.Tim Wright, Editor, Contract Pharma 03.17.21
-
Breaking News | Collaborations & Alliances | Industry News | Parenterals | Solid Dosage/Creams/Ointments
Gilead and Merck Ink HIV Agreement
Collaboration to focus on oral and injectable formulations of lenacapavir and islatravir.Tim Wright, Editor, Contract Pharma 03.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine
Will make manufacturing capacity available at IDT’s facilities in Germany to manufacture the single-shot COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 03.15.21
